EUVIMEDEUVIMED entdecken
Crossref

Patchouli alcohol against renal fibrosis of spontaneously hypertensive rats via Ras/Raf-1/ERK1/2 signalling pathway

Jing Li, Guanying Hu, Wenxiu Liu, Xiaoyu Cao, Guanru Chen, Fu Peng, Xie Xiaofang iD, Cheng Peng

Journal of Pharmacy and Pharmacology · 2023

DOI: 10.1093/jpp/rgad032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2023. Verfasst von Jing Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of standardization of Chinese herbal medicine of MOE, Chengdu University of…. Hauptthemen laut MEDLINE: Hypertension, Hypertension, Renal. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 83 Literaturangaben. Gefördert von: Multidimensional evaluation, Multi-dimensional evaluation of characteristic TCM resources and product development, Chengdu University of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The present study was designed to obverse the protection of patchouli alcohol (PA) ameliorates hypertensive nephropathy in spontaneously hypertensive rats (SHR) and reveals potential mechanism.

Methods

Briefly, the adult spontaneously hypertensive rats (SHR) or Wistar–Kyoto (WKY) rats (half male and half female) were intragastric gavaged or not with PA (80, 40 and 20 mg/kg) for 8 weeks. Body weight, blood pressure (BP), renal weight, renal function and renal morphology were measured. Further, western blotting and immunohistochemical analysis were used to study the underlying mechanism. Key findings Compared with the WKY group, plasmatic levels of renin, angiotensin II (Ang-II), transforming growth factor beta 1(TGF-β1), plasminogen activator inhibitor-1(PAI-1), creatinine (Cr), blood urea nitrogen (BUN), renal index, mRNA levels of ERK1/2 and α-SMA were significantly increased in SHR. Histology results showed that renal tubular injury and tubulointerstitial fibrosis occurred in SHR. After administration, SBP of captopril group decreased at each week after administration, especially at 3, 5, 6 7 and 8 weeks (P < 0.05 or P < 0.01). There is no significant effect was assessed in the olive oil group. Decreased plasma Cr, Renin, Ang-II, TGF-β1, PAI-1, SCFAs and Renin, TGF-β1, PAI-1 in renal tissues were observed significantly in captopril (P <0.05 or P < 0.01). Plasma BUN, Ang-II, TGF-β1 and PAI-1 in renal tissues decreased in the olive oil group significantly (P <0.05 or P < 0.01). PA (80, 40 and 20 mg/kg) lowered BP and plasmatic levels of Renin, Ang-II, TGF-β1 and PAI-1. Treatment with PA (40, 20 mg/kg) decreased levels of Cr, BUN and suppressed of activation of pro-fibrosis cytokines including TGF-β1 in kidney. There is no ameliorative change in the olive oil group and the captopril group (P > 0.05) while PA treatment alleviated renal tubular injury and produced dramatic collagen fibre area reductions in mesangial membrane, basement membrane, and renal interstitium obviously (P < 0.05 or P < 0.01). Treatment of SHR with PA-inhibited MFB activation and downregulated mRNA of α-SMA. Treatment with PA suppressed excessive production of the extracellular matrix (ECM) via decreasing Col I, III and FN, downregulating mRNA of tissue inhibitor of TIMP-1 along with upregulating mRNA of MMP-9. The expression of Col III and MMP-9 mRNA-reduced in the captopril group (P < 0.05). In addition, the expression of ERK1/2 and pERK1/2 also reduced in the captopril group significantly (P < 0.05 or P < 0.01). Treatment with PA (20 mg/kg) downregulated proteins expression of Raf-1, ERK1/2 and pERK1/2 and mRNA expression of Ras, Raf-1 and ERK1/2.

Conclusions

Overall, PA restored normal BP, alleviated renal dysfunction and renal fibrosis, possibly by suppressing Ang II and TGF-β1-mediated Ras/Raf-1/ERK1/2 signalling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionHypertension, RenalRatsAnimalsMaleFemaleRats, Inbred SHRTransforming Growth Factor beta1Plasminogen Activator Inhibitor 1Matrix Metalloproteinase 9CaptoprilRats, Inbred WKYReninMAP Kinase Signaling SystemOlive OilRNA, MessengerFibrosisSesquiterpenes

Stichwörter der Autor:innen

Ras/Raf-1/ERK1/2 signalling pathwayTGF-β1fibrosishypertensive nephropathypatchouli alcoholspontaneously hypertensive rats

Substanzen

Transforming Growth Factor beta1Plasminogen Activator Inhibitor 1Matrix Metalloproteinase 9CaptoprilReninOlive OilRNA, Messengerpatchouli alcoholSesquiterpenes

Autor:innen und Institutionen

  • Key Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of standardization of Chinese herbal medicine of MOE, Chengdu University of Traditional Chinese Medicine, Chengdu, PR China.
  • Department of Pharmacology, Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Indus…

ORCID-Profile: Xie Xiaofang

Förderung

  • Multidimensional evaluation
  • Multi-dimensional evaluation of characteristic TCM resources and product development
  • Chengdu University of Traditional Chinese Medicine
  • Sichuan Provincial Youth Science and Technology

Zitieren

APA

Li, J., Hu, G., Liu, W., Cao, X., Chen, G., Peng, F., Xiaofang, X., & Peng, C. (2023). Patchouli alcohol against renal fibrosis of spontaneously hypertensive rats via Ras/Raf-1/ERK1/2 signalling pathway. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgad032

Vancouver

Li J, Hu G, Liu W, Cao X, Chen G, Peng F, et al. Patchouli alcohol against renal fibrosis of spontaneously hypertensive rats via Ras/Raf-1/ERK1/2 signalling pathway. Journal of Pharmacy and Pharmacology. 2023. doi:10.1093/jpp/rgad032

BibTeX
@article{Li2023,
  author = {Li, Jing and Hu, Guanying and Liu, Wenxiu and Cao, Xiaoyu and Chen, Guanru and Peng, Fu and Xiaofang, Xie and Peng, Cheng},
  title = {Patchouli alcohol against renal fibrosis of spontaneously hypertensive rats via Ras/Raf-1/ERK1/2 signalling pathway},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2023},
  doi = {10.1093/jpp/rgad032}
}
Kostenlos starten →